ZYUS Life Sciences Corporation has seen notable volatility this week, with a significant dip in its stock price.
ZYUS Life Sciences Corporation (ZYUS.V) is experiencing a challenging week, with its stock price down 26.67% over the past five trading days. As of the latest close, the stock is holding at C$0.55. Despite the recent downturn, the stock has shown a 10% increase over the past month, although it remains down 19.12% year-to-date. Investors may be keen to understand the underlying factors driving this price action.
Investor takeaway: With no major news impacting ZYUS Life Sciences this week, investors should consider the technical indicators and volume trends to gauge potential future movements.
Advertisement
ZYUS Life Sciences Corporation
ZYUS.V
ZYUS.V
ZYUS Life Sciences Corporation
WealthAwesomeMarket cap
$44.04M
52W high
$0.75
52W low
$0.40
1W change
-26.67%
Beta
0.46
Analyst Price Targets
Based on analyst covering ZYUS · as of Sep 17, 2026
Wall Street analysts forecast ZYUS stock price to rise 172.7% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$1.50
+172.7% Upside
Current Price
C$0.55
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on ZYUS's historical volatility
30-Day Vol
193.8%
Annualized
90-Day Vol
127.4%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$0.46
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.52 | C$0.27 – C$1.01 |
| 60 trading days | C$0.49 | C$0.19 – C$1.26 |
| 90 trading days | C$0.46 | C$0.14 – C$1.46 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
C$0.55
ZYUS Life Sciences Corporation's stock closed at C$0.55, marking a 26.67% decline this week amidst low trading volume.
Bull case
Analysts are optimistic about ZYUS, with an average target price of C$1.50. This suggests a potential upside of 172.7%, reflecting confidence in the company's long-term prospects in the healthcare sector.
Bear case
Concerns about ZYUS's financial health arise from its negative profit margin and significant return on equity (ROE). The recent volatility may also deter risk-averse investors, making them cautious about the stock's future performance.
Recent Price Action
ZYUS Life Sciences Corporation's stock has closed at C$0.55, reflecting no change in price over the last trading day. However, the stock has experienced a 26.67% decline over the past week, highlighting significant volatility. In contrast, the stock has appreciated by 10% over the past month, which may indicate some resilience in the face of broader market fluctuations.
Advertisement
Technical Picture
From a technical perspective, ZYUS is currently trading above its 50-day moving average of C$0.51, which is a positive sign at +7.6%. However, it is slightly below its 200-day moving average of C$0.56, raising concerns about a potential long-term downtrend. The stock has a 52-week range of C$0.40 to C$0.75, with its current price at 43% of this range. With a beta of 0.46, ZYUS is considered less volatile compared to the broader market. The trading volume has been relatively low, with the latest volume at 6,001 shares, which is only 0.37 times the 20-day average volume of 16,032 shares.
Insider Activity
Currently, there are no reported insider activities for ZYUS Life Sciences Corporation. Investors often look at insider trading as a signal of confidence or concern from those closest to the company.
Analyst Outlook
Despite the recent price decline, analysts remain optimistic about ZYUS Life Sciences Corporation, assigning an average target price of C$1.50. This implies a significant upside potential of 172.7% from the current price. Such bullish sentiment may reflect confidence in the company's long-term growth prospects, particularly within the healthcare sector.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
